Home > Specialties > Reagents, Immunoassay, Tumor Marker, Protein, Monoclonal Ig, Light Chain, Kappa

Reagents, Immunoassay, Tumor Marker, Protein, Monoclonal Ig, Light Chain, Kappa

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (typically in serum, but also in urine) to determine kappa light chains, as fragments of monoclonal immunoglobulins (paraproteins). The presence of kappa light chains Ig in serum is used in the diagnosis of some malignant neoplasms, such as multiple myeloma, plasmacytoma, and amyloid disease.

Entry Terms : "Kappa Reagents, Light Chain Monoclonal Immunoglobulin"

UMDC code : 19088

   

1-9 of 9 Match(es).

Beckman Coulter GmbH

Beckman Coulter GmbH

Beckman Coulter Inc

Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs.

Beckman Coulter Inc

Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs.

HyTest Ltd

HyTest Ltd

ID Labs (Australia)

ID Labs (Australia)

ID Labs Inc (Canada)

ID Labs Inc (Canada)

ID Labs Inc (United Kingdom)

ID Labs Inc (United Kingdom)

Quartett Immunodiagnostika und

Quartett Immunodiagnostika und

The Binding Site Inc

At Binding Site we constantly strive to improve the tools available to laboratory professionals around the world for diagnosing and monitoring disease. Our origins date back to a group of researchers within the Medical School of Birmingham University who first started looking at innovative ways of producing antibodies in the early 1970's. With a desire to continue this early work but lacking the required government funding they founded a private company to take the research forward and utilise any potential commercial benefits. That company has evolved into The Binding Site and for over 25 years we have specialised in producing highly sensitive and highly specific antibodies used for the detection of certain cancers and other serious disorders.

1-9 of 9 Match(es).

 

Medical Product Guide Optometric Management Product Guide